Xenova (XNVA) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Xenova (XNVA)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who started this subject	4/7/2004 4:29:53 AM
From: nigel bates	of 173

Xenova Signs Lease Agreement with Genzyme SLOUGH, U.K., April 7, 2004 (PRIMEZONE) -- Xenova Group plc (LSE: XEN.L )announced today that it has signed a 10 year agreement with Genzyme Limited ("Genzyme (NASDAQ: GENZ) ") leasing to them the vacant space in the 310 Cambridge Science Park site. Genzyme will establish its first European discovery research facility on the site this month. Xenova will continue to occupy part of the Cambridge site together with its adjacent manufacturing facility. David Oxlade, Chief Executive Officer said: "We are pleased to welcome Genzyme as a tenant at our Cambridge facility. This, together with the disposal of research premises in Farnham in December, largely completes the planned reduction in UK facilities occupation following the acquisition of KS Biomedix Holdings plc in September 2003. Genzyme's occupation will substantially reduce our facilities overheads over the coming years." ...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next